Drugs / Advax1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02335164 | Jul 2015 → Dec 2017 | avian influenza | Vaxine Pty Ltd | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Advax1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02335164 ↗ |
| Modality | Other / unclassified | “Advax adjuvants which are based on delta inulin” NCT02335164 ↗ |
| Route | Intramuscular | “Advax1 adjuvant 20mg, i.m. injection” NCT02335164 ↗ |